225 related articles for article (PubMed ID: 23953906)
1. NOACs for thromboprophylaxis in medical patients.
Cohen AA; Rider T
Best Pract Res Clin Haematol; 2013 Jun; 26(2):183-90. PubMed ID: 23953906
[TBL] [Abstract][Full Text] [Related]
2. Novel oral anticoagulants for thromboprophylaxis after orthopaedic surgery.
Quinlan DJ; Eriksson BI
Best Pract Res Clin Haematol; 2013 Jun; 26(2):171-82. PubMed ID: 23953905
[TBL] [Abstract][Full Text] [Related]
3. Novel oral anticoagulants: a review of new agents.
Wanat MA
Postgrad Med; 2013 Jul; 125(4):103-14. PubMed ID: 23933899
[TBL] [Abstract][Full Text] [Related]
4. Novel oral anticoagulants for VTE prevention in orthopedic surgery: overview of phase 3 trials.
Friedman RJ
Orthopedics; 2011 Oct; 34(10):795-804. PubMed ID: 21956181
[TBL] [Abstract][Full Text] [Related]
5. New oral anticoagulants in elderly patients.
Barco S; Cheung YW; Eikelboom JW; Coppens M
Best Pract Res Clin Haematol; 2013 Jun; 26(2):215-24. PubMed ID: 23953909
[TBL] [Abstract][Full Text] [Related]
6. Novel oral anticoagulants in non-valvular atrial fibrillation.
Potpara TS; Lip GY
Best Pract Res Clin Haematol; 2013 Jun; 26(2):115-29. PubMed ID: 23953900
[TBL] [Abstract][Full Text] [Related]
7. New anticoagulants in the treatment of patients with cancer-associated venous thromboembolism.
den Exter PL; Kooiman J; van der Hulle T; Huisman MV
Best Pract Res Clin Haematol; 2013 Jun; 26(2):163-9. PubMed ID: 23953904
[TBL] [Abstract][Full Text] [Related]
8. [Management of direct action oral anticoagulants in the peri-operative period and invasive techniques].
Llau JV; Ferrandis R; Castillo J; de Andrés J; Gomar C; Gómez-Luque A; Hidalgo F; Torres LM;
Rev Esp Anestesiol Reanim; 2012; 59(6):321-30. PubMed ID: 22633209
[TBL] [Abstract][Full Text] [Related]
9. [Prophylaxis of venous thromboembolism in orthopedic surgery. Role of the new anticoagulants].
Guijarro Merino R; Villalobos Sánchez A
Med Clin (Barc); 2012 Oct; 139 Suppl 2():13-8. PubMed ID: 23498067
[TBL] [Abstract][Full Text] [Related]
10. [New anticoagulants: dabigatran, rivaroxaban and apixaban].
Vargas Ruiz AG; Ramírez López AN; Medina Viramontes ME
Gac Med Mex; 2012; 148(3):257-64. PubMed ID: 22820359
[TBL] [Abstract][Full Text] [Related]
11. Treatment discontinuations with new oral agents for long-term anticoagulation: insights from a meta-analysis of 18 randomized trials including 101,801 patients.
Chatterjee S; Sardar P; Giri JS; Ghosh J; Mukherjee D
Mayo Clin Proc; 2014 Jul; 89(7):896-907. PubMed ID: 24996233
[TBL] [Abstract][Full Text] [Related]
12. Dabigatran, rivaroxaban and apixaban versus enoxaparin for thomboprophylaxis after total knee or hip arthroplasty: pool-analysis of phase III randomized clinical trials.
Nieto JA; Espada NG; Merino RG; González TC
Thromb Res; 2012 Aug; 130(2):183-91. PubMed ID: 22425218
[TBL] [Abstract][Full Text] [Related]
13. Anticoagulation: a GP primer on the new oral anticoagulants.
Brieger D
Aust Fam Physician; 2014 May; 43(5):254-9. PubMed ID: 24791763
[TBL] [Abstract][Full Text] [Related]
14. [Recommendations on use of direct oral anticoagulants in the perioperative period].
Llau JV; Ferrandis R; Castillo J; de Andrés J; Gomar C; Gómez-Luque A; Hidalgo F; Torres LM
Med Clin (Barc); 2012 Oct; 139 Suppl 2():46-50. PubMed ID: 23498073
[TBL] [Abstract][Full Text] [Related]
15. New anticoagulant drugs for treatment of venous thromboembolism and stroke prevention in atrial fibrillation.
Tripodi A; Palareti G
J Intern Med; 2012 Jun; 271(6):554-65. PubMed ID: 22443239
[TBL] [Abstract][Full Text] [Related]
16. Novel oral anticoagulants in patients with renal insufficiency: a meta-analysis of randomized trials.
Sardar P; Chatterjee S; Herzog E; Nairooz R; Mukherjee D; Halperin JL
Can J Cardiol; 2014 Aug; 30(8):888-97. PubMed ID: 25064581
[TBL] [Abstract][Full Text] [Related]
17. [New anticoagulants: better knowledge, better prescriptions].
Boehlen F; de Moerloose P
Rev Med Suisse; 2012 Jan; 8(324):96-9. PubMed ID: 23185817
[TBL] [Abstract][Full Text] [Related]
18. Novel oral anticoagulants for stroke prevention in atrial fibrillation: focus on apixaban.
Potpara TS; Polovina MM; Licina MM; Stojanovic RM; Prostran MS; Lip GY
Adv Ther; 2012 Jun; 29(6):491-507. PubMed ID: 22684583
[TBL] [Abstract][Full Text] [Related]
19. Disadvantages of VKA and requirements for novel anticoagulants.
Shameem R; Ansell J
Best Pract Res Clin Haematol; 2013 Jun; 26(2):103-14. PubMed ID: 23953899
[TBL] [Abstract][Full Text] [Related]
20. New oral anticoagulants--a review.
Ghanima W; Atar D; Sandset PM
Tidsskr Nor Laegeforen; 2013 Oct; 133(18):1940-5. PubMed ID: 24084970
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]